These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11363897)
1. Developing long-term treatment strategies. PI Perspect; 1996 Sep; (No 19):11-4. PubMed ID: 11363897 [TBL] [Abstract][Full Text] [Related]
2. Salvage therapy for patients failing their current antiretroviral regimen. Albrecht MA AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220 [No Abstract] [Full Text] [Related]
6. Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil. Pilcher CD; Perkins MD; Fiscus SA; Johnston DM; Dietze R; Duque UH; Zago AM; Assad-Antunes F; Eron JJ J Infect Dis; 1999 May; 179(5):1259-63. PubMed ID: 10191233 [TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment of HIV infection. Thomas MG; Ellis-Pegler RB N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818 [No Abstract] [Full Text] [Related]
8. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885 [No Abstract] [Full Text] [Related]
9. Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients? Knobel H Clin Infect Dis; 2005 Jan; 40(1):164-6. PubMed ID: 15614707 [No Abstract] [Full Text] [Related]
10. Antiviral update. PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy: where are we? Hammer SM; Yeni P AIDS; 1998; 12 Suppl A():S181-8. PubMed ID: 9633001 [No Abstract] [Full Text] [Related]
12. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS). De Clercq E Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005 [TBL] [Abstract][Full Text] [Related]
13. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS. Porche DJ Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281 [TBL] [Abstract][Full Text] [Related]
14. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement? Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R; Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650 [TBL] [Abstract][Full Text] [Related]
16. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023 [TBL] [Abstract][Full Text] [Related]
17. What's new in HIV. Morris-Jones S; Nelson MR J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641 [No Abstract] [Full Text] [Related]
18. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens. Joly V; Descamps D; Yeni P AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447 [TBL] [Abstract][Full Text] [Related]
19. Targeting HIV: antiretroviral therapy and development of drug resistance. Menéndez-Arias L Trends Pharmacol Sci; 2002 Aug; 23(8):381-8. PubMed ID: 12377580 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa. van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]